Ads

You May Also Like

Curetis Subsidiary Ares Genetics Launches ARES & CO Pharma Partnering Program

Curetis Subsidiary Ares Genetics Launches ARES & CO Pharma Partnering Program Program aims to ...

XBiotech Provides Update on Xilonix™ Phase III Programs in US and EU

AUSTIN, Texas, July 22, 2016 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT), developer of next-generation ...

Terveystalo Group Interim Report 1 January – 30 September 2018

Terveystalo Plc. Interim report 14 November 2018 at 9:00 a.m. EET Strong earnings trend ...